Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2010 17:00 ET | Source: MediciNova, Inc.

MediciNova's MN-166 Program Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch

SAN DIEGO, Oct. 19, 2010 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
September 27, 2010 06:00 ET | Source: MediciNova, Inc.

UCLA Initiates a NIDA-Supported Phase 1b Study With Ibudilast in Methamphetamine-Dependent Volunteers

SAN DIEGO, Sept. 27, 2010 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities...
September 02, 2010 06:00 ET | Source: MediciNova, Inc.

MediciNova to Present at the Rodman and Renshaw Annual Global Investment Conference

SAN DIEGO, Sept. 2, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
August 16, 2010 17:10 ET | Source: MediciNova, Inc.

MediciNova Reports Second Quarter 2010 Results

SAN DIEGO, Aug. 16, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
July 12, 2010 16:30 ET | Source: MediciNova, Inc.

MediciNova Announces Estimated Timing of Payments to Former Avigen Stockholders

SAN DIEGO, July 12, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
July 07, 2010 16:30 ET | Source: MediciNova, Inc.

Insight on MediciNova's MN-166 Mechanism of Action Reported in Proceedings of the National Academy of Sciences

SAN DIEGO, July 7, 2010 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities...
July 06, 2010 16:30 ET | Source: MediciNova, Inc.

MediciNova Nets $9.5 Million From Settlement of Auction Rate Securities Held by UBS

SAN DIEGO, July 6, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
June 14, 2010 17:05 ET | Source: MediciNova, Inc.

MediciNova Appoints Michael Coffee as Chief Business Officer

SAN DIEGO, June 14, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
May 17, 2010 17:05 ET | Source: MediciNova, Inc.

MediciNova Reports First Quarter 2010 Results

SAN DIEGO, May 17, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
May 11, 2010 06:00 ET | Source: MediciNova, Inc.

MediciNova Secures $15 Million Debt Facility From Oxford Finance Corporation

SAN DIEGO, May 11, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...